Indication
Cardiovascular Abnormalities
5 clinical trials
7 products
Clinical trial
Phase 1 Safety-interaction Study of Mirtazapine for the Treatment of Methamphetamine Use DisorderStatus: Recruiting, Estimated PCD: 2025-12-31
Product
MirtazapineProduct
MethamphetamineClinical trial
A Prospective Study of Early Stage Breast Cancer Patients With Abnormal Myocardial Deformation Treated With Anthracycline and/or Trastuzumab and Pertuzumab-based Cancer TherapyStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
CarvedilolClinical trial
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.Status: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Contribution of the Integrase Inhibitor Dolutegravir to Obesity and Cardiovascular Disease in Persons Living With HIVStatus: Completed, Estimated PCD: 2022-06-17
Product
DolutegravirProduct
AntiretroviralClinical trial
Utility of Novel Echocardiographic and Invasive Haemodynamic Measurements in the Assessment of Patients Low Flow Low Gradient Aortic Stenosis Undergoing TAVIStatus: Completed, Estimated PCD: 2024-03-01
Product
Dobutamine